HL7 FHIR Implementation Guide Dossier Farmaceutico
0.1.1 - ci-build Italy flag

HL7 FHIR Implementation Guide Dossier Farmaceutico, published by HL7 Italia. This guide is not an authorized publication; it is the continuous build for version 0.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-it/dossier-pharma/ and changes regularly. See the Directory of published versions

ValueSet: Regole di sostituzione

Official URL: http://hl7.it/fhir/dossier-pharma/ValueSet/substitution-it-dossierPharma Version: 0.1.1
Active as of 2024-06-24 Computable Name: VsSubstitutionDossierPharma

Regole di sostituzione permesse per le prescrizioni inviate al dossier farmaceutico

References

Logical Definition (CLD)

 

Expansion

Expansion based on codesystem Substance Admin Substitution v3.0.0 (CodeSystem)

This value set contains 10 concepts

LevelCodeSystemDisplayDefinition
1  _ActSubstanceAdminSubstitutionCodehttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionActSubstanceAdminSubstitutionCode

Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

2    Ehttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

3      EChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent composition

Description:

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
4        BChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionbrand composition

Description:

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
4        Ghttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiongeneric composition

Description: Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
3      TEhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic alternative

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
4        TBhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic brand

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
4        TGhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic generic

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
2    Fhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionformulary

Description: This substitution was performed or is permitted based on formulary guidelines.

2    Nhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionnone

No substitution occurred or is permitted.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code